February 24, 2017
OncoGenex has enough money for next year as it waits a mid-year merger with Achieve Life Sciences
Vancouver-based drugmaker OncoGenex didn’t make any revenues in the fourth quarter 2016, and it finished the year with a net loss for the fourth quarter and year ended December 31, 2016 of $5.8 million and $20.1 million, respectively.